PeptideDB

Carisbamate

CAS: 194085-75-1 F: C9H10ClNO3 W: 215.63

Carisbamate (RWJ-333369) is an orally active neuromodulator. Carisbamate prevents the development and production of epil
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Carisbamate (RWJ-333369) is an orally active neuromodulator. Carisbamate prevents the development and production of epilep-like discharges and has a neuroprotective effect after in vitro epilepticus-like injury. Carisbamate has good antiepileptic activity in genetic models of generalized and nonconvulsive epilepsy[1][2][3].
Invitro Carisbamate (200 µM; 12 h) exhibits antiepileptic effects on SREDs model of hippocampal cells[1].Carisbamate (200 µM; 24 h) shows long lasting effects on the hippocampal neurons that are independent from antiepileptic effects in vitro[1].Carisbamate not only inhibits the development and expression of SREDs in the majority of neurons, but also decreases seizure frequency and duration in the few neurons that still has an occasional epileptiform event[1].Carisbamate (200 µM) shows neuroprotective effects on hippocampal cells with SE (status epilepticus)-like injury[1]. Cell Viability Assay[1] Cell Line:
In Vivo Carisbamate (10, 30, 60 mg/kg; i.p.; single) dose dependently reduces the expression of spike-and-wave discharges (SWD) in absence seizures rat model[2].Carisbamate (20, 30 mg/kg; i.p.; single) shows no wild running episode or tonic seizure occurres in any of the rats tested[2]. Animal Model:
Name Carisbamate
CAS 194085-75-1
Formula C9H10ClNO3
Molar Mass 215.63
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Deshpande LS, et al. Carisbamate prevents the development and expression of spontaneous recurrent epileptiform discharges and is neuroprotective in cultured hippocampal neurons. Epilepsia. 2008 Oct;49(10):1795-802. [2]. François J, et al. Effects of carisbamate (RWJ-333369) in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS. Epilepsia. 2008 Mar;49(3):393-9. [3]. Novak GP, et al. Carisbamate (RWJ-333369). Neurotherapeutics. 2007 Jan;4(1):106-9.